The intermediate risk pathway for patients with a HPV (not 16/18) +ve cervical screening test result changed on 1st February 2021 based on new data collected from the National Cervical Screening Program. In order to support best-practice clinical care, this presentation will explain what the changes to the pathway are for patients at low risk and higher risk of underlying high grade abnormalities.